HDAC4-AS2 and melanoma: In the present report, we identify a new polypeptide of the MELOE family, MELOE-3, and describe its expression and its immunogenicity in comparison with that of MELOE-1 to evaluate its potential value as a T cell target for melanoma immunotherapy.